comprehensive -WSS

comprehensive

author：comprehensive 2025-09-28 23:49:49 - browse：9

Abbott's heart device TriClip on a gradient dark blue background — coverage from STAT — The device is called the TriClip, and it addresses a disease called tricuspid regurgitation: a heart condition that causes blood to leak backward through the tricuspid heart valve. Illustration: STAT; Photo: Courtesy Abbott

An advisory panel to the Food and Drug Administration voted in favor of a new device from Abbott meant to treat patients with tricuspid heart valve disease. All but one of the 14 panelists said the treatment’s benefits outweighed its risks. The FDA tends to follow advisory panel recommendations.

“If we can help symptoms with this at a low cost in terms of risk, I think it makes a lot of sense,” said James Blankenship, a panelist and cardiologist at the University of New Mexico.

The device is called the TriClip, and it addresses a disease called tricuspid regurgitation: a heart condition that causes blood to leak backward through the tricuspid heart valve. The condition impacts 1.6 million people in the United States. Symptoms include fatigue, swelling, and atypical heart rhythms. In severe cases, the condition can lead to heart failure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： FDA drug safety: Singulair case shows systemic surveillance flaws

WSS

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Germany receives 178 compensation applications from gay servicepeople over discrimination

Vertigo drug brings hope for rare neuron disorder, Niemann

Vertigo drug brings hope for rare neuron disorder, Niemann

Biden praises World Series champion Astros for impact off the field during White House celebration

Medicare drug price negotiation’s day in court

focus

comprehensive

knowledge

Virginia high school admissions case could be legal follow

Cognito secures funding to test medical device for Alzheimer's

BioMarin wins approval for gene therapy to treat hemophilia A

Astronauts get first look at the spacecraft that will fly them around the moon

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Germany receives 178 compensation applications from gay servicepeople over discrimination

Alkermes shareholders re

Medicare drug price negotiation’s day in court

Moonlake's readout produced a cash windfall. Risks remain

Cognito secures funding to test medical device for Alzheimer's

hotspot

Cognito secures funding to test medical device for Alzheimer's

Cybersecurity threat forces Lurie Children's to take systems offline

General Catalyst, Summa Health deal will turn on physician buy

The painfully weak evidence on taking collagen to treat arthritis

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

The painfully weak evidence on taking collagen to treat arthritis

knowledge

entertainment

hotspot

knowledge